81 related articles for article (PubMed ID: 6651412)
1. Mechanism of the hypotensive action of practolol in the anesthetized rat.
Davy M; Lindenbaum A; Cohen Y; Wepierre J
Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):283-92. PubMed ID: 6651412
[TBL] [Abstract][Full Text] [Related]
2. [Hypotensive effects of practolol and atenolol after blood-brain barrier lesion in normotensive and hypertensive rats].
Davy M; Lindenbaum A; Cohen Y; Wepierre J
Paroi Arterielle; 1980; 6(4):219-24. PubMed ID: 7329713
[TBL] [Abstract][Full Text] [Related]
3. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
Davy M; Midol-Monnet M; Heimburger M; Wepierre J; Cohen Y
J Pharmacol; 1986; 17(1):28-36. PubMed ID: 2872366
[TBL] [Abstract][Full Text] [Related]
4. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
Takami N; Sugawara K; Ozaki M
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
[TBL] [Abstract][Full Text] [Related]
5. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
Sugawara K; Takami N; Ozaki M
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
Matsunaga K; Ueda M
Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide.
Moreira TS; Takakura AC; Sato MA; Menani JV; Colombari E
J Cardiovasc Pharmacol; 2006 Jun; 47(6):780-7. PubMed ID: 16810079
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effect of a standardized aqueous extract of Cecropia glaziovii Sneth in rats: an in vivo approach to the hypotensive mechanism.
Lima-Landman MT; Borges AC; Cysneiros RM; De Lima TC; Souccar C; Lapa AJ
Phytomedicine; 2007 May; 14(5):314-20. PubMed ID: 17446057
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
Ruffolo RR; Kurz K; Paget CJ
J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104
[TBL] [Abstract][Full Text] [Related]
10. The effect of beta-adrenergic receptor blocking agents on hypertensive action of noradrenaline injected into the lateral ventricle of rat brain.
Kleinrok Z; Ksiazek A
Pol J Pharmacol Pharm; 1977; 29(4):405-9. PubMed ID: 20610
[TBL] [Abstract][Full Text] [Related]
11. Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.
Farsang C; Ramirez-Gonzalez MD; Tchakarov L; Kunos G
Acta Physiol Hung; 1983; 62(2):167-75. PubMed ID: 6670566
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiovascular activity of beta-adrenoceptor blocking drugs in awake or anaesthetized normotensive and hypertensive rats.
Davy M; Midol-Monnet M; Cohen Y; Wepierre J
Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):257-78. PubMed ID: 603320
[TBL] [Abstract][Full Text] [Related]
13. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
14. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
[TBL] [Abstract][Full Text] [Related]
16. Mode of antihypertensive action of nitrendipine.
Kazda S; Garthoff B; Luckhaus G
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S956-62. PubMed ID: 6085384
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive action of elcatonin].
Takayanagi N; Tozuka T; Toda N
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):383-93. PubMed ID: 6671629
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
Wellens D; Snoeckx L; De Reese R; Kruger R; Van de Water A; Woutens L; Reneman RS
Arch Int Pharmacodyn Ther; 1975 May; 215(1):119-32. PubMed ID: 1156041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
